D83.2
Common variable immunodeficiency with autoantibodies to B- or T-cells
Clinical Classification Guidelines
Medical Intelligence & Overview
Common Variable Immunodeficiency (CVID) with autoantibodies, classified under ICD-10 code D83.2, is a primary immune system disorder characterized by the body's inability to produce adequate antibodies. This condition can lead to increased susceptibility to infections and may also involve the immune system mistakenly attacking the body's own tissues due to the presence of autoantibodies targeting B-cells or T-cells. Understanding CVID with autoantibodies can help in managing the condition effectively and recognizing its signs and symptoms early.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting immune system development Autoantibodies disrupting normal B-cell or T-cell function Environmental factors triggering immune system abnormalities Unknown factors contributing to immune dysregulation in some cases
Key Symptoms: Frequent or recurrent respiratory infections such as sinusitis, bronchitis, or pneumonia Persistent infections affecting the ears, sinuses, or skin Digestive issues like diarrhea or malabsorption due to infections or autoimmune processes Autoimmune phenomena including autoimmune hemolytic anemia or thrombocytopenia Swelling of lymph nodes or spleen Fatigue and general malaise Low levels of immunoglobulins (antibodies) detected in blood tests In some cases, inflammation and tissue damage caused by autoimmune responses
Diagnostic & Treatment
Diagnosis Path: Diagnosing CVID with autoantibodies involves a combination of clinical evaluation and laboratory testing. Key diagnostic steps include: - Measurement of immunoglobulin levels (IgG, IgA, IgM) in the blood, typically showing decreased levels - Testing for the presence of autoantibodies targeting B-cells or T-cells - Assessing the frequency and severity of infections - Excluding other causes of immunodeficiency - Possibly performing lymphocyte subset analysis to evaluate the function of B-cells and T-cells - Imaging studies or biopsies may be used to identify organ involvement or autoimmune tissue damage Early diagnosis is crucial for managing the condition effectively and preventing complications.
Treatment Protocols: While there is no cure for CVID with autoantibodies, treatment focuses on managing symptoms, preventing infections, and controlling autoimmune activity. Common approaches include: - Regular immunoglobulin replacement therapy to boost antibody levels - Antibiotic treatments for active infections - Surveillance and management of autoimmune symptoms - Immunosuppressive medications in certain cases to control autoimmune responses - Vaccinations to prevent common infections, tailored to individual immune status - Monitoring organ function and addressing complications as they arise A multidisciplinary healthcare team can help develop a personalized treatment plan tailored to each patient's needs.
Clinical Advice & FAQs
Billing Guidance
Is D83.2 a billable ICD-10 code?
Yes, D83.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D83.2?
Clinical documentation must specify the nature of Common variable immunodeficiency with autoantibodies to B- or T-cells and any associated comorbidities for accurate reporting.
Cite this Clinical Reference